Drug Description in Trials / DrugBank / KEGG DRUG

Search results

descriptions per page:

Showing 1 to 10 of 144 descriptions

Filter by |

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

0.5 mg budesonide effervescent tablet for orodispersible use

[1] Budesonide 💬

[1] NR3C1 💬

[1] Neuroactive ligand-receptor interaction 💬

[1] 98 💬

2

1 mg budesonide effervescent tablet for orodispersible use

[1] Budesonide 💬

[1] NR3C1 💬

[1] Neuroactive ligand-receptor interaction 💬

[1] 98 💬

3

1mg budesonide effervescent tablet for orodispersible use

[1] Budesonide 💬

[1] NR3C1 💬

[1] Neuroactive ligand-receptor interaction 💬

[1] 98 💬

4

2mg budesonide effervescent tablet for orodispersible use

[1] Budesonide 💬

[1] NR3C1 💬

[1] Neuroactive ligand-receptor interaction 💬

[1] 98 💬

5

5 mg Montelukast

[1] Montelukast

[1] Montelukast 💬

[1] CYSLTR1 💬

[2] Calcium signaling pathway, Neuroactive ligand-receptor interaction 💬

[1] 98 💬

6

-

-

-

-

[1] 98 💬

7

Allergy immunotherapy (allergy shots)

-

-

-

-

[1] 98 💬

8

Alpha-proteinase inhibitor

-

-

-

-

[1] 98 💬

9

[1] Tezepelumab

[1] Tezepelumab 💬

[1] TSLP 💬

[2] Cytokine-cytokine receptor interaction, JAK-STAT signaling pathway 💬

[1] 98 💬

10

-

-

-

-

[1] 98 💬

First Previous1 2 3 4 5…15Next Last